KR20150046328A - 신경 전달을 억제하기 위한 테르펜 화합물을 포함하는 조성물 및 방법 - Google Patents

신경 전달을 억제하기 위한 테르펜 화합물을 포함하는 조성물 및 방법 Download PDF

Info

Publication number
KR20150046328A
KR20150046328A KR20157008120A KR20157008120A KR20150046328A KR 20150046328 A KR20150046328 A KR 20150046328A KR 20157008120 A KR20157008120 A KR 20157008120A KR 20157008120 A KR20157008120 A KR 20157008120A KR 20150046328 A KR20150046328 A KR 20150046328A
Authority
KR
South Korea
Prior art keywords
pain
compounds
neuropathic pain
geraniol
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR20157008120A
Other languages
English (en)
Korean (ko)
Inventor
알렉산더 맥러렌
프랭크 그린웨이
Original Assignee
네우로퀘스트 아이엔씨.
보드 오브 슈퍼바이저스 오브 루이지애나 스테이트 유니버시티 앤드 애그리컬추얼 앤드 메카니컬 컬리지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 네우로퀘스트 아이엔씨., 보드 오브 슈퍼바이저스 오브 루이지애나 스테이트 유니버시티 앤드 애그리컬추얼 앤드 메카니컬 컬리지 filed Critical 네우로퀘스트 아이엔씨.
Publication of KR20150046328A publication Critical patent/KR20150046328A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Neurosurgery (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
KR20157008120A 2007-02-06 2008-02-06 신경 전달을 억제하기 위한 테르펜 화합물을 포함하는 조성물 및 방법 Withdrawn KR20150046328A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89964207P 2007-02-06 2007-02-06
US60/899,642 2007-02-06
PCT/CA2008/000236 WO2008095297A1 (en) 2007-02-06 2008-02-06 Composition comprising terpene compounds and methods for inhibiting nerve transmission

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020097018619A Division KR101580857B1 (ko) 2007-02-06 2008-02-06 신경 전달을 억제하기 위한 테르펜 화합물을 포함하는 조성물 및 방법

Publications (1)

Publication Number Publication Date
KR20150046328A true KR20150046328A (ko) 2015-04-29

Family

ID=39681217

Family Applications (2)

Application Number Title Priority Date Filing Date
KR20157008120A Withdrawn KR20150046328A (ko) 2007-02-06 2008-02-06 신경 전달을 억제하기 위한 테르펜 화합물을 포함하는 조성물 및 방법
KR1020097018619A Expired - Fee Related KR101580857B1 (ko) 2007-02-06 2008-02-06 신경 전달을 억제하기 위한 테르펜 화합물을 포함하는 조성물 및 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020097018619A Expired - Fee Related KR101580857B1 (ko) 2007-02-06 2008-02-06 신경 전달을 억제하기 위한 테르펜 화합물을 포함하는 조성물 및 방법

Country Status (9)

Country Link
US (2) US9999601B2 (enExample)
EP (1) EP2142182B1 (enExample)
JP (2) JP5933164B2 (enExample)
KR (2) KR20150046328A (enExample)
CN (2) CN105581999A (enExample)
AU (1) AU2008213772A1 (enExample)
CA (1) CA2676139C (enExample)
HK (1) HK1224231A1 (enExample)
WO (1) WO2008095297A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105581999A (zh) 2007-02-06 2016-05-18 安元有限公司 用于抑制神经传导的包括萜烯化合物的组合物以及方法
WO2008112641A2 (en) 2007-03-09 2008-09-18 New York University Methods and compositions for treating thalamocortical dysrhythmia
CA2732784C (en) * 2008-08-13 2018-09-18 Neuroquest Inc. Compositions comprising terpene compounds for treating negative sensory phenomena
CA2811241A1 (en) * 2010-09-14 2012-03-22 Neuroquest Inc. Terpenoid analogues and uses thereof for treating neurological conditions
WO2012053003A1 (en) * 2010-10-18 2012-04-26 Anil Kumar Gupta A novel herbal oil for controlling blood sugar without risk of hypoglycemea
CA2841972A1 (en) * 2011-07-14 2013-01-17 Neuroquest Inc. Terpene analogues and uses thereof for treating neurological conditions
US9228727B2 (en) 2012-04-05 2016-01-05 Michael W. May Lighting assembly
WO2013168090A1 (en) 2012-05-07 2013-11-14 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Researc Organization (Aro) (Volcanii Center). Geranium oil and constituents thereof for treatment of neurodegenerative diseases
WO2014051113A1 (ja) 2012-09-28 2014-04-03 株式会社資生堂 Ｖｅｇｆｃ産生促進剤
WO2014187946A1 (en) * 2013-05-24 2014-11-27 Nestec S.A. Treatment or prevention of autism disorders using menthol, linalool and/or icilin
US10493042B2 (en) 2013-08-01 2019-12-03 University-Industry Cooperation Group Of Kyung Hee University Method for preventing or treating diabetes mellitus, and method for screening for diabetes mellitus therapeutic agent
WO2015016682A1 (ko) 2013-08-01 2015-02-05 경희대학교 산학협력단 당뇨병 예방 또는 치료용 약학적 조성물, 당뇨병 예방 또는 치료 방법, 및 당뇨병 치료제 스크리닝 방법
KR102250582B1 (ko) 2018-05-11 2021-05-12 고려대학교 산학협력단 별아교세포 특이적 수동전도도 억제약물의 스크리닝 시스템 및 이의 활용

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555333A (en) 1975-05-29 1979-11-07 Bush Boake Allen Ltd Perfumery compositions comprising hydroxy- or alkoxy-substituted c9 alkanals alkanols and esters
NZ190416A (en) 1978-05-16 1981-05-29 Unilever Ltd Deodorant product
CH673931A5 (enExample) 1986-05-08 1990-04-30 R & C Products Pty Ltd
DE3779500T2 (de) 1986-06-10 1993-01-21 Chiesi Farma Spa Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
DE3725248A1 (de) 1987-07-30 1989-02-09 Henkel Kgaa Antimikrobiell wirksame, aromatisierte zubereitungen
US5770738A (en) 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
US5260313A (en) * 1992-03-12 1993-11-09 National Pain Institute, Inc. Diagnosis and treatment of various neuralgias
US6248307B1 (en) 1999-04-14 2001-06-19 Standard Homeopathic Company Compositions and treatment for alleviation of symptoms associated with menopause
EP1424071B1 (en) 2001-08-08 2008-08-20 Shiseido Company Limited Perfume compositions
US20030092636A1 (en) 2001-11-06 2003-05-15 Silberstein Stephen D. Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
AU2002360517A1 (en) * 2001-12-07 2003-06-23 Ximed Group Plc Respiratory infection prevention and treatment with terpene-containing compositions
US20030224072A1 (en) * 2002-06-03 2003-12-04 Frome Bruce Marshall Topical and oral administration of a composition containing Pelargonium Graveolens for diagnosis and treatment of various neuralgias and other conditions
US7943166B2 (en) * 2003-04-10 2011-05-17 Neurogesx, Inc. Methods and compositions for administration of TRPV1 agonists
US20050025823A1 (en) * 2003-07-29 2005-02-03 Fong Andy A.T. Methods of use of herbal compositions
US20050112183A1 (en) 2003-11-25 2005-05-26 Galer Bradley S. Compositions and methods for treating neuropathic sensory loss
US20060004050A1 (en) 2004-07-02 2006-01-05 Speicher Brian T Compositions and methods for the prevention or treatment of pain and other nervous system disorders
WO2006105481A1 (en) * 2005-03-30 2006-10-05 Neurogesx, Inc. Low-concentration capsaicin patch and methods for treating neuropathic pain
US20070203080A1 (en) 2006-02-15 2007-08-30 The Regents Of The University Of California New Drug Delivery System for Crossing the Blood Brain Barrier
WO2008108825A2 (en) 2006-10-10 2008-09-12 Burnham Institute For Medical Research Neuroprotective compositions and methods
KR20090082507A (ko) * 2006-11-20 2009-07-30 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 통증 및 소양증 치료용 방법, 조성물 및 키트
CN105581999A (zh) * 2007-02-06 2016-05-18 安元有限公司 用于抑制神经传导的包括萜烯化合物的组合物以及方法
US8236239B2 (en) 2007-11-16 2012-08-07 Bernstein Eric F Sterilizing compositions comprising phosphors for converting electromagnetic radiation to UVC radiation and methods for using the same
GB2460214A (en) 2008-03-20 2009-11-25 Hexcel Composites Ltd Prepregs for use in making laminates of reduced porosity
FR2934925B1 (fr) * 2008-08-06 2011-02-25 Soitec Silicon On Insulator Procede de fabrication d'une structure comprernant une etape d'implantations d'ions pour stabiliser l'interface de collage.
CA2732784C (en) 2008-08-13 2018-09-18 Neuroquest Inc. Compositions comprising terpene compounds for treating negative sensory phenomena
WO2010057295A1 (en) 2008-11-18 2010-05-27 Origin Biomed Inc. Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain
CA2811241A1 (en) 2010-09-14 2012-03-22 Neuroquest Inc. Terpenoid analogues and uses thereof for treating neurological conditions
CA2841972A1 (en) 2011-07-14 2013-01-17 Neuroquest Inc. Terpene analogues and uses thereof for treating neurological conditions

Also Published As

Publication number Publication date
CN105581999A (zh) 2016-05-18
WO2008095297A1 (en) 2008-08-14
HK1224231A1 (zh) 2017-08-18
JP2016121169A (ja) 2016-07-07
AU2008213772A1 (en) 2008-08-14
KR20100014922A (ko) 2010-02-11
US9999601B2 (en) 2018-06-19
JP2010518030A (ja) 2010-05-27
EP2142182A4 (en) 2010-03-03
CA2676139A1 (en) 2008-08-14
US20180207110A1 (en) 2018-07-26
JP6144785B2 (ja) 2017-06-07
EP2142182A1 (en) 2010-01-13
JP5933164B2 (ja) 2016-06-08
CN101677973A (zh) 2010-03-24
EP2142182B1 (en) 2017-09-27
KR101580857B1 (ko) 2015-12-30
CA2676139C (en) 2016-04-26
US20110257255A1 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
KR101580857B1 (ko) 신경 전달을 억제하기 위한 테르펜 화합물을 포함하는 조성물 및 방법
Batiha et al. A review of the bioactive components and pharmacological properties of Lavandula species
US20160317466A1 (en) Compositions comprising terpene compounds for treating negative sensory phenomena
JP2021525709A (ja) 自閉症スペクトラム障害の治療のためのカンナビスベースの組成物
US20030224072A1 (en) Topical and oral administration of a composition containing Pelargonium Graveolens for diagnosis and treatment of various neuralgias and other conditions
Liang et al. Therapeutic potential of cannabinoids in trigeminal neuralgia
US20240131038A1 (en) Anti-inflammatory compositions comprising cannabidiol, delta-9-tetrahydrocannabinol and linalool
KR20080113478A (ko) 항염활성을 갖는 미성숙 감귤 정유추출물
Imam The Cream which relieves the pain of Menstrual cramps without interfering with the Hormones or Period Cycle
KR100341368B1 (ko) 심혈관 질환 치료제의 조성 및 그의 제조방법
US20170136081A1 (en) Composition and method for the treatment of neuropathic pain
Huntsman et al. Cannabis for pediatric and adult epilepsy
McLellan et al. Compositions comprising terpene compounds for treating negative sensory phenomena
Mathew An Unexplored Under-recognized
DE202024103583U1 (de) Cannabinoid Zusammensetzung zur Verwendung bei der Behandlung von Schmerzen und/oder Entzündungen
AU2024315631A1 (en) Composition for use in treatment and/or prevention of chronic musculoskeletal pain including chronic low back pain, chronic non-specific low back pain, osteoarthritis or other chronic musculoskeletal pain conditions comprising delta-9-tetrahydrocannabinol and terpenes

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20150330

Application number text: 1020097018619

Filing date: 20090904

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20150528

Patent event code: PE09021S01D

PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 20151021

WITB Written withdrawal of application